Specific sputum markers, including higher sputum eosinophils, macrophages, and lymphocyte counts, were associated with remission after interleukin-5 (IL-5)–targeted therapy for patients with severe ...

Mepolizumab and benralizumab are both potent targets of the interlukin-5 pathway with the ability to significantly reduce eosinophil counts, according to new research published in Allergy, Asthma & ...

This transcript has been edited for clarity. Michael Wechsler, MD: Hello. I'm Dr Mike Wechsler and welcome to Medscape's InDiscussion series on moderate to severe asthma. This is episode three of the ...

Based on decades of work to uncover the underlying mechanisms of asthma and other respiratory conditions, researchers at McMaster University and St. Joseph's Healthcare Hamilton have produced a simple ...

Researchers have developed a new rapid sputum-based test that can identify the presence of a key driver of severe asthma, white blood cells. A simple, rapid testing device has the potential to detect ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Four sputum type 2 markers may predict 1-year remission ...

Authors of a UK study in this week's issue of THE LANCET suggest that targeting the underlying cause of asthma--rather than treating symptoms of the disorder--could be more effective in reducing ...

HAMILTON, ON, Aug. 1, 2023 – Based on decades of work to uncover the underlying mechanisms of asthma and other respiratory conditions, researchers at McMaster University and St. Joseph’s Healthcare ...

REDWOOD CITY, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody ...